185 related articles for article (PubMed ID: 26863523)
21. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2019; 35(6):319-321. PubMed ID: 31241399
[No Abstract] [Full Text] [Related]
22. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2015 Sep; 31(7):363-4. PubMed ID: 26262823
[No Abstract] [Full Text] [Related]
23. Transporters and receptors in ocular drug delivery: opportunities and challenges.
Dey S; Mitra AK
Expert Opin Drug Deliv; 2005 Mar; 2(2):201-4. PubMed ID: 16296747
[TBL] [Abstract][Full Text] [Related]
24. Ocular drug delivery.
Goepferich A
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):157. PubMed ID: 26004820
[No Abstract] [Full Text] [Related]
25. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2017; 33(6):423-425. PubMed ID: 28618236
[No Abstract] [Full Text] [Related]
26. Ocular Therapeutics: Drug Delivery and Pharmacology.
Dickmann L
Mol Pharm; 2016 Sep; 13(9):2875-6. PubMed ID: 27596048
[No Abstract] [Full Text] [Related]
27. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2019 Oct; 35(8):421-422. PubMed ID: 31414924
[No Abstract] [Full Text] [Related]
28. Eyes on new product development.
Novack GD
J Ocul Pharmacol Ther; 2015 Feb; 31(1):1. PubMed ID: 25562125
[No Abstract] [Full Text] [Related]
29. Eyes on new product development.
Novack GD
J Ocul Pharmacol Ther; 2013 Nov; 29(9):785. PubMed ID: 24175582
[No Abstract] [Full Text] [Related]
30. Industrial perspective in ocular drug delivery.
Ali Y; Lehmussaari K
Adv Drug Deliv Rev; 2006 Nov; 58(11):1258-68. PubMed ID: 17079049
[TBL] [Abstract][Full Text] [Related]
31. Are contact lenses the solution for effective ophthalmic drug delivery?
Bengani L; Chauhan A
Future Med Chem; 2012 Nov; 4(17):2141-3. PubMed ID: 23190101
[No Abstract] [Full Text] [Related]
32. Eyes on new product development.
Novack GD
J Ocul Pharmacol Ther; 2014 Oct; 30(8):603-4. PubMed ID: 25280174
[No Abstract] [Full Text] [Related]
33. Eyes on new product development.
Novack GD
J Ocul Pharmacol Ther; 2013 Jun; 29(5):449. PubMed ID: 23725200
[No Abstract] [Full Text] [Related]
34. Hydrogels in ophthalmic applications.
Kirchhof S; Goepferich AM; Brandl FP
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):227-38. PubMed ID: 26032290
[TBL] [Abstract][Full Text] [Related]
35. Randomizing 1 eye or 2 eyes: a missed opportunity.
Glassman AR; Melia M
JAMA Ophthalmol; 2015 Jan; 133(1):9-10. PubMed ID: 25256889
[No Abstract] [Full Text] [Related]
36. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2017 Jun; 33(5):335-336. PubMed ID: 28441083
[No Abstract] [Full Text] [Related]
37. Advanced drug delivery systems for therapeutic applications.
Sung HW; Liu Z
Adv Healthc Mater; 2014 Aug; 3(8):1130-2. PubMed ID: 25124801
[No Abstract] [Full Text] [Related]
38. Intraocular implants for extended drug delivery: therapeutic applications.
Bourges JL; Bloquel C; Thomas A; Froussart F; Bochot A; Azan F; Gurny R; BenEzra D; Behar-Cohen F
Adv Drug Deliv Rev; 2006 Nov; 58(11):1182-202. PubMed ID: 17107737
[TBL] [Abstract][Full Text] [Related]
39. Eyes on new product development.
Novack GD
J Ocul Pharmacol Ther; 2014 Nov; 30(9):687. PubMed ID: 25375289
[No Abstract] [Full Text] [Related]
40. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2015 Nov; 31(9):509-10. PubMed ID: 26468598
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
